Premium
Role of CYP2D6 in the Demethylation of Fluoxetine In Vivo
Author(s) -
Hamelin B.A.,
Turgeon J.,
Vallée F.,
Belanger P.M.,
Paquet F.,
LeBel M.
Publication year - 1996
Publication title -
clinical pharmacology and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.941
H-Index - 188
eISSN - 1532-6535
pISSN - 0009-9236
DOI - 10.1038/sj.clpt.1996.48
Subject(s) - clinical pharmacology , fluoxetine , demethylation , pharmacology , in vivo , cyp2d6 , chemistry , medicine , biology , biochemistry , genetics , cytochrome p450 , metabolism , serotonin , receptor , gene expression , dna methylation , gene
Clinical Pharmacology & Therapeutics (1996) 59 , 137–137; doi: 10.1038/sj.clpt.1996.48